Insmed Incorporated
INSM
$149.33
-$0.67-0.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 263.84M | 142.34M | 107.42M | 92.82M | 104.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 263.84M | 142.34M | 107.42M | 92.82M | 104.44M |
| Cost of Revenue | 44.22M | 29.37M | 28.08M | 21.28M | 26.15M |
| Gross Profit | 219.62M | 112.98M | 79.34M | 71.55M | 78.29M |
| SG&A Expenses | 212.48M | 186.38M | 154.76M | 147.55M | 142.52M |
| Depreciation & Amortization | 1.94M | 1.54M | 1.26M | 1.26M | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 513.55M | 403.69M | 361.29M | 322.66M | 349.66M |
| Operating Income | -249.71M | -261.35M | -253.88M | -229.84M | -245.21M |
| Income Before Tax | -326.93M | -368.70M | -320.44M | -255.67M | -234.28M |
| Income Tax Expenses | 1.55M | 1.32M | 1.24M | 912.00K | 1.27M |
| Earnings from Continuing Operations | -328.49M | -370.02M | -321.69M | -256.58M | -235.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -328.49M | -370.02M | -321.69M | -256.58M | -235.55M |
| EBIT | -249.71M | -261.35M | -253.88M | -229.84M | -245.21M |
| EBITDA | -244.68M | -257.89M | -250.66M | -227.23M | -243.01M |
| EPS Basic | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 |
| Normalized Basic EPS | -0.75 | -0.78 | -0.86 | -0.82 | -0.87 |
| EPS Diluted | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 |
| Normalized Diluted EPS | -0.75 | -0.78 | -0.86 | -0.82 | -0.87 |
| Average Basic Shares Outstanding | 213.64M | 211.76M | 189.30M | 180.86M | 179.02M |
| Average Diluted Shares Outstanding | 213.64M | 211.76M | 189.30M | 180.86M | 179.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |